Specific and Reliable Detection of Myosin 1C Isoform A by RTqPCR in Prostate Cancer Cells

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2018 Dec 1

PMID 30498638

Citations 5

Authors

Aleena A Saidova

Daria M Potashnikova

Anna V Tvorogova

Ivan V Maly

Wilma A Hofmann

Ivan A Vorobjev

Affiliations

Soon will be listed here.

Abstract

Background: Prostate cancer (PC) diagnostics and treatment often present a challenging task due to cancer subtype heterogeneity and differential disease progression in patient subgroups. Hence, the critical issue is finding a reliable and sensitive diagnostic and prognostic PC marker, especially for cases of biopsies with low percentages of cancer cells. Isoform A of myosin 1C was shown to be expressed in PC cells and responsible for their invasive properties, however, its feasibility for diagnostic purposes remains to be elucidated.

Methods: To verify the role of myosin 1C isoform A mRNA expression as a putative prostate cancer marker we performed RT qPCR normalized by three reference genes () on PC3, RWPE-1, LNCaP and 22Rv1 cell lines. Myosin 1C isoform A detection specificity was confirmed by immunofluorescence staining, cancer and non-cancer prostate cell lines were immunophenotyped by flow cytometry.

Results: Median normalized mRNA expression level of myosin 1C isoform A in PC cells (PC3 and 22Rv1) is two orders of magnitude higher compared to RWPE-1 cells, which functionally correspond to benign prostate cells. Myosin 1C isoform A expression allows PC cell detection even at a dilution ratio of 1:1000 cancer to non-cancer cells. At the protein level, the mean fluorescence intensity of myosin 1C isoform A staining in PC3 nuclei was only twice as high as in RWPE-1, while the immunophenotypes of both cell lines were similar (CD44+/CD90-/CD133-/CD57-/CD24+-).

Conclusions: We report a distinct difference in myosin 1C isoform A mRNA levels in malignant (PC3) and benign (RWPE-1) prostate cell lines and suggest a combination of three reference genes for accurate data normalization. For the first time we provide an immunophenotype comparison of RWPE-1 and PC3 cells and demonstrate that RT qPCR analysis of using appropriate reference genes is sufficient for PC detection even in low-abundance cancer specimens.

Citing Articles

Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP/ABCG2).

da Silva Zanzarini I, Henrique Kita D, Scheiffer G, Karoline Dos Santos K, de Paula Dutra J, Augusto Pastore M Bioorg Chem. 2024; 146:107283.

PMID: 38513324 PMC: 11069345. DOI: 10.1016/j.bioorg.2024.107283.

Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors.

de Paula Dutra J, Scheiffer G, Kronenberger T, Gomes L, Zanzarini I, Karoline Dos Santos K EXCLI J. 2024; 22:1155-1172.

PMID: 38204967 PMC: 10776880. DOI: 10.17179/excli2023-6427.

Parameters of Cell Death and Proliferation of Prostate Cancer Cells with Altered Expression of Myosin 1C Isoforms.

Solomatina E, Nishkomaeva E, Kovaleva A, Tvorogova A, Potashnikova D, Saidova A Dokl Biochem Biophys. 2024; 514(1):16-22.

PMID: 38189886 PMC: 11021239. DOI: 10.1134/S1607672923700588.

Myosin 1C isoform A is a novel candidate diagnostic marker for prostate cancer.

Saidova A, Potashnikova D, Tvorogova A, Paklina O, Veliev E, Knyshinsky G PLoS One. 2021; 16(5):e0251961.

PMID: 34019593 PMC: 8139512. DOI: 10.1371/journal.pone.0251961.

Effect of Palmitic Acid on Exosome-Mediated Secretion and Invasive Motility in Prostate Cancer Cells.

Maly I, Hofmann W Molecules. 2020; 25(12).

PMID: 32545453 PMC: 7355791. DOI: 10.3390/molecules25122722.

References

Horoszewicz J, Leong S, Chu T, Wajsman Z, Friedman M, Papsidero L . The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res. 1980; 37:115-32. View

Liu S, Zhu P, Zhang L, Ding S, Zheng S, Wang Y . Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis. Cancer Biomark. 2014; 13(5):345-9. DOI: 10.3233/CBM-130365. View

Zhao H, Ma T, Lin J, Liu L, Sun W, Guo L . Identification of valid reference genes for mRNA and microRNA normalisation in prostate cancer cell lines. Sci Rep. 2018; 8(1):1949. PMC: 5792445. DOI: 10.1038/s41598-018-19458-z. View

Jaworska D, Szliszka E . Targeting Apoptotic Activity Against Prostate Cancer Stem Cells. Int J Mol Sci. 2017; 18(8). PMC: 5578038. DOI: 10.3390/ijms18081648. View

Thompson I, Chi C, Ankerst D, Goodman P, Tangen C, Lippman S . Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst. 2006; 98(16):1128-33. DOI: 10.1093/jnci/djj307. View

Zhang C, Wang Y, Jin G, Wu S, Cui J, Wang R . Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction. Oncol Lett. 2017; 14(5):6001-6011. PMC: 5661485. DOI: 10.3892/ol.2017.7002. View

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

Zhao H, Peehl D . Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts. Prostate. 2009; 69(9):991-1000. PMC: 2736596. DOI: 10.1002/pros.20946. View

Vogel C, Marcotte E . Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012; 13(4):227-32. PMC: 3654667. DOI: 10.1038/nrg3185. View

10.

Roh M, Franco O, Hayward S, van der Meer R, Abdulkadir S . A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. PLoS One. 2008; 3(7):e2572. PMC: 2440349. DOI: 10.1371/journal.pone.0002572. View

11.

Wotschofsky Z, Meyer H, Jung M, Fendler A, Wagner I, Stephan C . Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Anal Biochem. 2011; 417(2):233-41. DOI: 10.1016/j.ab.2011.06.009. View

12.

Mori R, Wang Q, Danenberg K, Pinski J, Danenberg P . Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate. 2008; 68(14):1555-60. DOI: 10.1002/pros.20815. View

13.

Mohammed A . Biomarkers in prostate cancer: new era and prospective. Med Oncol. 2014; 31(8):140. DOI: 10.1007/s12032-014-0140-3. View

14.

Shappell S, Thomas G, Roberts R, Herbert R, Ittmann M, Rubin M . Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res. 2004; 64(6):2270-305. DOI: 10.1158/0008-5472.can-03-0946. View

15.

Seim I, Jeffery P, Thomas P, Nelson C, Chopin L . Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines. G3 (Bethesda). 2017; 7(6):1731-1741. PMC: 5473753. DOI: 10.1534/g3.117.039909. View

16.

True L, Zhang H, Ye M, Huang C, Nelson P, von Haller P . CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker. Mod Pathol. 2010; 23(10):1346-56. PMC: 2948633. DOI: 10.1038/modpathol.2010.122. View

17.

Potashnikova D, Gladkikh A, Vorobjev I . Selection of superior reference genes' combination for quantitative real-time PCR in B-cell lymphomas. Ann Clin Lab Sci. 2015; 45(1):64-72. View

18.

Souza A, Simoni Brum I, Silva Neto B, Berger M, Branchini G . Reference gene for primary culture of prostate cancer cells. Mol Biol Rep. 2012; 40(4):2955-62. DOI: 10.1007/s11033-012-2366-5. View

19.

Richardson G, Robson C, Lang S, Neal D, Maitland N, Collins A . CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci. 2004; 117(Pt 16):3539-45. DOI: 10.1242/jcs.01222. View

20.

Pellacani D, Packer R, Frame F, Oldridge E, Berry P, Labarthe M . Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Mol Cancer. 2011; 10:94. PMC: 3162587. DOI: 10.1186/1476-4598-10-94. View